Fluosphera
1 known investors
FluoSphera develops an in vitro drug discovery platform that combines encapsulated multi-tissue organoids into a multi-organ system to mimic human systemic responses and predict clinical drug outcomes before trials. The technology enables high-resolution drug profiling for pharmaceutical and drug discovery research.